Company Profile
PathoFinder is a privately owned nucleic acid diagnostics company founded in 2004. The company focuses on the development and commercialization of a new generation of molecular diagnostics, with special emphasis on infectious disease. Our proprietary MultiFinder technology allows for the detection and differentiation of up to 20 viral and bacterial pathogens in a single assay.
PathoFinder has established collaborations with several clinical and academic centers in the Netherlands as well as several institutes across Europe.
PathoFinder is based in Maastricht, The Netherlands. The company’s founder and CEO is Guus Simons, Ph.D. Before founding PathoFinder, Guus Simons worked for eleven years at Keygene, Wageningen, The Netherlands, where he held positions as project manager and business manager and for nine years as project leader at the Netherlands Institute for Dairy Research. He performed his post-doc period at the University of Ghent, Belgium after he got his Ph.D. in molecular biology at the University of Nijmegen, The Netherlands. Guus Simons has written more than 50 peer reviewed papers and 15 patent applications.
